EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Review on Neuroprotective Activity and Pharmacological Mechanisms of Bacopa monnieri in Various Animal Models of Alzheimer's Disease

Saleema Dudekula, Praveen Kumar Pasala, Usman Muazu Muhammad, Parameswar G V, Abubakar Mohamedali Omer Idress

Journal of Pharma Insights and Research · 05.06.2026 · 4 (3) · 389-401

DOI: 10.69613/1tn14g79 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharma Insights and Research, online erschienen am 05.06.2026. Verfasst von Saleema Dudekula und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease is a progressive neurodegenerative condition characterized by complex multifactorial neuropathology, including amyloid-beta aggregation, tau hyperphosphorylation, oxidative stress, cholinergic deficits, and neuroinflammation. Bacopa monnieri and its bioactive dammarane-type triterpenoid saponins display multifaceted neuroprotective actions across transgenic, naturally aged, invertebrate, and neurotoxin-induced experimental models. An evaluation of these experimental models shows that Bacopa monnieri exerts polypharmacological effects by suppressing soluble amyloid-beta accumulation, downregulating glycogen synthase kinase-3 beta (GSK-3β) activity to decrease tau hyperphosphorylation, upregulating the Nrf2/HO-1 antioxidant pathway, inhibiting nuclear factor kappa B (NF-κ B)-driven inflammatory cascades, and stabilizing central cholinergic transmission through acetylcholinesterase inhibition. Additional structural and functional benefits include the enhancement of hippocampal neurogenesis and synaptic plasticity. Despite these consistent preclinical findings, barriers remain due to extract composition variability, a predominant focus on prophylactic rather than therapeutic treatment paradigms, male-biased animal cohorts, and limited pharmacokinetic profiling. Extract standardization and evaluating therapeutic intervention windows in clinically representative models are the main requirements for advancing this botanical candidate toward clinical validation

Zitieren

APA

Dudekula, S., Pasala, P. K., Muhammad, U. M., V, P. G., & Idress, A. M. O. (2026). A Review on Neuroprotective Activity and Pharmacological Mechanisms of Bacopa monnieri in Various Animal Models of Alzheimer's Disease. Journal of Pharma Insights and Research, 4(3), 389-401. https://doi.org/10.69613/1tn14g79

Vancouver

Dudekula S, Pasala PK, Muhammad UM, V PG, Idress AMO. A Review on Neuroprotective Activity and Pharmacological Mechanisms of Bacopa monnieri in Various Animal Models of Alzheimer's Disease. Journal of Pharma Insights and Research. 2026;4(3):389-401. doi:10.69613/1tn14g79

BibTeX
@article{Dudekula2026,
  author = {Dudekula, Saleema and Pasala, Praveen Kumar and Muhammad, Usman Muazu and V, Parameswar G and Idress, Abubakar Mohamedali Omer},
  title = {A Review on Neuroprotective Activity and Pharmacological Mechanisms of Bacopa monnieri in Various Animal Models of Alzheimer's Disease},
  journal = {Journal of Pharma Insights and Research},
  year = {2026},
  volume = {4},
  number = {3},
  pages = {389--401},
  doi = {10.69613/1tn14g79}
}
Kostenlos starten →